South Okanagan MMPR Application Update

JUNE 18, 2014

 

June 18th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to report that the target company (or the “Vendor”) at Facility 1 has received and replied to the Department of Health Canada on its Marihuana for Medical Purposes Regulations Licence (MMPR) application, who required additional information on:

  • External and internal security measures
  • Updated site survey and aerial photographs
  • Further information on principal and proposed technical employees
  • Details on record keeping and information handling procedures

The Vendor has engaged external consultants and specialists to assist in the application process who have been able to respond and provide the requested documentation in a timely manner. While the Vendor is confident that their prior experience and expertise in the industry and the high commercial standards of the production facility will enable full compliance with Department of Health requirements for a full commercial MMPR license, there is no guarantee a MMPR license will be granted.
Last week management of Supreme and its operating subsidiary met with government officials, including the fire chief, local politicians, and community stakeholders in the township where its Southern Ontario green house facility (Facility 2) is located. The Company does not foresee any concerns in this area as construction progresses such that it may eventually receive final receipt of the MMPR license.

Management of Supreme stated: “We are pleased to be making headway on both projects, being the South Okanagan and Southern Ontario facilities. The Company is moving forward and will continue to update shareholders on continued progress.”

Contact Information

Investor Relations
430 – 580 Hornby Street, Vancouver BC
V6C 3B6
Phone: (647) 340-6744
Email: info@supreme.ca
Website: www.supreme.ca

FORWARD LOOKING INFORMATION

>This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the up grading of the facility, the timing on completetion of the MMPR License conditions and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com and such factors as the Company failing to finish the upgrading of the facility and put the same into production in accordance within the terms of the MMPR license. This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.